Kenneth B. Miller

No ORCID on file · 2 papers in corpus
observational 2002
American journal of hematology ·doi:10.1002/ajh.10209

Thrombocytopenia is a poor prognostic indicator in the myelodysplastic syndromes (MDS). Treatment options for patients with symptomatic thrombocytopenia are limited. Danazol, an attenuated androgen, may have some efficacy in increasing the …

case-report 1987
British journal of haematology ·doi:10.1111/j.1365-2141.1987.tb06878.x